These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16944190)

  • 1. Differential immunogold localisation of sulphated and unsulphated keratan sulphate proteoglycans in normal and macular dystrophy cornea using sulphation motif-specific antibodies.
    Young RD; Akama TO; Liskova P; Ebenezer ND; Allan B; Kerr B; Caterson B; Fukuda MN; Quantock AJ
    Histochem Cell Biol; 2007 Jan; 127(1):115-20. PubMed ID: 16944190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypes of macular corneal dystrophy in India and correlation with mutations in CHST6.
    Sultana A; Klintworth GK; Thonar EJ; Vemuganti GK; Kannabiran C
    Mol Vis; 2009; 15():319-25. PubMed ID: 19204788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the CHST6 gene in patients with macular corneal dystrophy: immunohistochemical evidence of heterogeneity.
    Iida-Hasegawa N; Furuhata A; Hayatsu H; Murakami A; Fujiki K; Nakayasu K; Kanai A
    Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3272-7. PubMed ID: 12882769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural localization of sulfated and unsulfated keratan sulfate in normal and macular corneal dystrophy type I.
    Lewis D; Davies Y; Nieduszynski IA; Lawrence F; Quantock AJ; Bonshek R; Fullwood NJ
    Glycobiology; 2000 Mar; 10(3):305-12. PubMed ID: 10704529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical classification of primary and recurrent macular corneal dystrophy in Germany: subclassification of immunophenotype I A using a novel keratan sulfate antibody.
    Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Haubeck HD; Küchle M; Naumann GO
    Exp Eye Res; 2001 Nov; 73(5):593-600. PubMed ID: 11747360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization and expression of CHST6 and keratan sulfate proteoglycans in the human cornea.
    Di Iorio E; Barbaro V; Volpi N; Bertolin M; Ferrari B; Fasolo A; Arnaldi R; Brusini P; Prosdocimo G; Ponzin D; Ferrari S
    Exp Eye Res; 2010 Aug; 91(2):293-9. PubMed ID: 20537995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular dystrophy of the cornea. A systemic disorder of keratan sulfate metabolism.
    Edward DP; Thonar EJ; Srinivasan M; Yue BJ; Tso MO
    Ophthalmology; 1990 Sep; 97(9):1194-200. PubMed ID: 2234853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of glycosaminoglycan distributions, keratan sulphate sulphation patterns and collagen fibril architecture from central to peripheral regions of the bovine cornea.
    Ho LT; Harris AM; Tanioka H; Yagi N; Kinoshita S; Caterson B; Quantock AJ; Young RD; Meek KM
    Matrix Biol; 2014 Sep; 38():59-68. PubMed ID: 25019467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel mutations in the carbohydrate sulfotransferase gene (CHST6) causing macular corneal dystrophy.
    El-Ashry MF; Abd El-Aziz MM; Wilkins S; Cheetham ME; Wilkie SE; Hardcastle AJ; Halford S; Bayoumi AY; Ficker LA; Tuft S; Bhattacharya SS; Ebenezer ND
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):377-82. PubMed ID: 11818380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoanalysis of keratan sulfate proteoglycan from corneal scars.
    Funderburgh JL; Cintron C; Covington HI; Conrad GW
    Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1116-24. PubMed ID: 2971024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of keratan sulphate (sulphated poly -N-acetyllactosamine repeats) in keratoconic cornea, histochemical, and ultrastructural analysis.
    Akhtar S; Bron AJ; Hayes AJ; Meek KM; Caterson B
    Graefes Arch Clin Exp Ophthalmol; 2011 Mar; 249(3):413-20. PubMed ID: 20853116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene.
    Akama TO; Nishida K; Nakayama J; Watanabe H; Ozaki K; Nakamura T; Dota A; Kawasaki S; Inoue Y; Maeda N; Yamamoto S; Fujiwara T; Thonar EJ; Shimomura Y; Kinoshita S; Tanigami A; Fukuda MN
    Nat Genet; 2000 Oct; 26(2):237-41. PubMed ID: 11017086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen Fibrils and Proteoglycans of Macular Dystrophy Cornea: Ultrastructure and 3D Transmission Electron Tomography.
    Akhtar S; Alkatan HM; Kirat O; Khan AA; Almubrad T
    Microsc Microanal; 2015 Jun; 21(3):666-79. PubMed ID: 25939479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macular corneal dystrophy: the macromolecular structure of the stroma observed using electron microscopy and synchrotron X-ray diffraction.
    Meek KM; Quantock AJ; Elliott GF; Ridgway AE; Tullo AB; Bron AJ; Thonar EJ
    Exp Eye Res; 1989 Dec; 49(6):941-58. PubMed ID: 2515072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular corneal dystrophy in Iceland. A clinical, genealogic, and immunohistochemical study of 28 patients.
    Jonasson F; Oshima E; Thonar EJ; Smith CF; Johannsson JH; Klintworth GK
    Ophthalmology; 1996 Jul; 103(7):1111-7. PubMed ID: 8684802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular corneal dystrophy. Lack of keratan sulfate in serum and cornea.
    Klintworth GK; Meyer R; Dennis R; Hewitt AT; Stock EL; Lenz ME; Hassell JR; Stark WJ; Kuettner KE; Thonar EJ
    Ophthalmic Paediatr Genet; 1986 Dec; 7(3):139-43. PubMed ID: 2951638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macular corneal dystrophy type II: multiple studies on a cornea with low levels of sulphated keratan sulphate.
    Quantock AJ; Fullwood NJ; Thonar EJ; Waltman SR; Capel MS; Ito M; Verity SM; Schanzlin DJ
    Eye (Lond); 1997; 11 ( Pt 1)():57-67. PubMed ID: 9246278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative biochemical and ultrastructural study of proteoglycan-collagen interactions in corneal stroma. Functional and metabolic implications.
    Scott JE; Bosworth TR
    Biochem J; 1990 Sep; 270(2):491-7. PubMed ID: 2119175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased GlcNAc 6-O-sulfotransferase activity in the cornea with macular corneal dystrophy.
    Hasegawa N; Torii T; Kato T; Miyajima H; Furuhata A; Nakayasu K; Kanai A; Habuchi O
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3670-7. PubMed ID: 11053262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunophenotype classification of macular corneal dystrophy: first case report of immunophenotype I A outside of Saudi Arabia. A clinical histopathological correlation with immunohistochemistry and electron microscopy].
    Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Küchle M
    Klin Monbl Augenheilkd; 2000 Aug; 217(2):118-26. PubMed ID: 11022667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.